Home / Knowledge Centre /

Almac validate Illumina TruSight® Tumor 170 Assay

*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to [email protected]. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.

In this webinar, Dr Leeona Galligan, VP UK Operations at Almac Diagnostic Services will discuss:

  • An overview on Almac Diagnostic Services
  • TruSight® Tumor 170 overview
  • TruSight® Tumor 170 Analytical Validation at Almac
  • Clinical Trial Framework for TruSight® Tumor 170 at Almac

For more information visit our Current Assay section.

View Resource

Please complete this form to view the Webinar

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies